Laser Vison Correction Results for Dishler LASIK in Denver Reveals 98% of Nearsighted Patients Achieve 20/25 or Better

Share Article

Custom All-Laser LASIK performed by Jon G. Dishler M. D. of the Dishler Laser Institute shows that Vision Results performed with the Zeiss VisuMax FS laser, M.E.L. 80 and Allegretto Wavelight lasers are outstanding with a patient satisfaction rate of 98%.

"Although most laser centers tell patients that their outcomes are excellent, we have looked at our actual results in different groups of patients. We present these to perspective patients to help them make an informed decision". Jon G. Dishler M.D.

When you are having surgery on your eyes, you need to know what to expect. LASIK results at Dishler Laser Institute are simply clearer. Data for LASIK surgeries performed by Dr. Jon G. Dishler of the Dishler Laser Institute (http://www.dishler.com) between January 1 and August 31, 2010 were recently compiled. Data for 1076 eyes were collected. 92% of eyes underwent LASIK; 8% PRK. 93% of patients were nearsighted and 7% of patients were farsighted. In the data complied, 100% of nearsighted patients achieved 20/30, 96% achieved 20/20, with 29% achieving 20/15 vision results. All results are for best monocular visual acuity achieved within 6 months post-op LASIK. No subject lost any best correctable visual acuity. 4 eyes out of 1,075 (0.4%) underwent an enhancement procedure and the post-enhancement visual acuity is included in the data. Laser technology used was the VisuMax All Laser Femtosecond Flap Maker & Zeiss M.E.L. 80 / Allegretto Wavelight Excimer lasers. Method of collection is on file at Dishler Laser Institute. Note: Past performance does not always predict future LASIK results.
LASIK surgery involves risks.

A specialist in refractive surgery, Dr. Dishler has personally performed over 51,000 LASIK and vision correction procedures during the last 15 years. He has participated in the original development of the Excimer laser within the framework of the FDA approval studies. In fact, he was the first laser vision surgeon and only ophthalmologist in Colorado to develop an FDA approved Excimer laser.

From the very beginning, Dr. Jon Dishler contributed to the development of the Femtosecond laser. He was awarded the Pioneer award laser for perfecting the design of the Femtosecond laser technology by the IntraLase Corporation. Currently, he is the first of four LASIK centers in the United States to perform LASIK with the Zeiss M.E.L. 80 Excimer and Visumax Femtosecond laser platform.

Dr. Dishler is an internationally -known and respected, refractive surgeon. He has been awarded several patents for inventions in his specialty including the FDA approved Dishler Excimer Laser, Excimer beam profiler, Insertion system for corneal implants, surgical visual feedback and eye fixation method and apparatus.

Jon Dishler M.D has held the title of Principal investigator for 10 FDA studies for laser manufacturers such as Bausch and Lomb, ReVision Optics, Meditec Carl Zeiss, and the Dishler Excimer laser.

About Dr. Dishler (http://www.dishler.com/pages/trusted-lasik-surgeon)
Dr. Dishler is a board certified ophthalmologist and a Fellow of the American College of Surgeons (F.A.C.S.). He graduated from the University of Colorado Medical School and completed his residency at the University of Texas. Dr. Dishler began practicing general ophthalmology in 1982. In 1985, he founded the DTC Eye Surgery Center which was one of Colorado's first state-certified ambulatory surgery centers.

Dr. Dishler has numerous groundbreaking achievements to his name. He was the first ophthalmologist in the state of Colorado to perform LASIK and Automated Lamellar Keratoplasty (ALK), and one of the first in the United States to perform the advanced all- laser IntraLASIK procedure. He also performed the first LASIK procedure for farsightedness in Colorado. Currently, Dr. Dishler is a lead investigator for Revision Optics, and with phase first completed, phase two of an FDA trial on the ReVision Vue + lens for treating farsightedness is in the process.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Rachel Gomez

303-793-3000
Email >
Visit website